Full name
BIOXUS LAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.45.Z - Wholesale trade of perfumes and cosmetics
10.41.Z - Production of oils and other liquid fats
19.20.Z - Manufacture and processing of petroleum refining products and products from fossil fuels
20.12.Z - Manufacture of dyes and pigments
20.42.Z - Manufacture of cosmetics and toilet preparations
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -6,3 | -19,1 | -9,6 | 50 |
Gross profit (loss) | -6,3 | -18,8 | -8,9 | 53 |
EBITDA | -6,3 | -19,1 | -9,6 | 50 |
Short time liabilities | 52,7 | 52,4 | 51,3 | -2,1 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 97,1 | 78,3 | 69,4 | -11,3 |
Operating profit (EBIT) | -6,3 | -19,1 | -9,6 | 50 |
Assets | 149,8 | 130,6 | 137,9 | 5,6 |
Net profit (loss) | -6,3 | -18,8 | -8,9 | 53 |
Cash | 80,8 | 77,4 | 42 | -45,7 |
Net income from sale | 0 | 0 | 80,9 | -∞ |
Liabilities and provisions for liabilities | 52,7 | 52,4 | 68,5 | 30,8 |
Working assets | 148,8 | 129,6 | 136,9 | 5,6 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -6,4 | -24,1 | -12,8 | 11,3 |
Equity capital to total assets | 64,8 | 59,9 | 50,3 | -9,6 |
Gross profit margin | -10,9 | 8,1 | ||
EBITDA Margin | -11,8 | 7,7 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 231 | -2 147 483 417 |
Current financial liquidity indicator | 2.8244707584381104 | 2.475708246231079 | 2.66984224319458 | 0,2 |
Net dept to EBITDA | 12.905976295471191 | 4.051516056060791 | 4.398634910583496 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane